Page 16 - KBM_3_2022_WEB

Chou, Y. J. Antibiotic prescribing for children with myxovirus resistance protein A (MxA). Pediatrics, 2015,
nasopharyngitis (common colds), upper respiratory 135, e985–93.
infections, and bronchitis who have health professional
parents. Pediatrics 2005, 116, 826–832.
35. Kalliolias, G. D., Ivashkiv, L. B. Overview of the biology Autoři prohlašují, že nejsou ve střetu zájmů.
of type I interferons. Arthritis. Res. Ther., 2010, 12, S1.
36. Toivonen L, Schuez-Havupalo L, Rulli M, Ilonen J, Do redakce došlo 10. 5. 2022
Pelkonen J, Melen K. Blood MxA protein as a marker
for respiratory virus infections in young children. J. Clin. Adresa pro korespondenci
Virol., 2015, 62, 8–13. Mgr. Monika Šrámková
37. Haller, O., Kochs, G. Human MxA protein: an interferon- Ústav lékařské chemie a klinické biochemie
induced dynamin-like GTPase with broad antiviral activity. 2. LF UK a FN Motol
J. Interferon Cytokine Res. 2011, 31, 79–87. V Úvalu 84
38. Engelmann, I., Dubos, F., Lobert, P. E., Houssin, C., 150 06 Praha 5
Degas, V., Sardet, A. Diagnosis of viral infections using e-mail: monika.sramkova@fnmotol.cz

78 Klinická biochemie a metabolismus 3/2022